Pharmaceutical Advisors
Pharmaceutical Advisors, LLC is a flexible, expert-driven company that supports drug development and commercialization programs without the need for clients to grow their infrastructure. They leverage a broad network of experienced advisors to provide targeted expertise, advice, and hands-on support across all phases of pharmaceutical development, including CMC, regulatory, DMPK, toxicology, pharmacology, and supply chain management. Their mission is to help clients progress efficiently while managing risk, cost, and time, with a focus on tailored support and rapid response.
Industries
Nr. of Employees
medium (51-250)
Pharmaceutical Advisors
Princeton, New Jersey, United States, North America
Patents
Solid forms for a thienopyrimidinedione ACC inhibitor and methods for production thereof
US-11104687-B2
View DetailsSolid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof
US-10487090-B2
View DetailsSolid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof
US-10183951-B2
View Details
Solid forms for a thienopyrimidinedione ACC inhibitor and methods for production thereof
US-11104687-B2
View DetailsSolid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof
US-10487090-B2
View DetailsSolid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof
US-10183951-B2
View DetailsServices
Short- or long-term advisory support across CMC, regulatory, non-clinical and quality functions.
Run entire development programs or manage discrete functional workstreams as an outsourced program lead.
Authoring, review and strategic planning for INDs, NDAs, BLAs, MAAs and other regulatory filings.
Provision of quality unit functions, development of QA/QC systems and phase-appropriate quality program implementation.
Vendor and site audits with local auditor engagement across multiple geographies.
Hands-on CMC support including preparation for manufacturing, API outsourcing advice, and oversight of manufacturing partners.
Short- or long-term advisory support across CMC, regulatory, non-clinical and quality functions.
Run entire development programs or manage discrete functional workstreams as an outsourced program lead.
Authoring, review and strategic planning for INDs, NDAs, BLAs, MAAs and other regulatory filings.
Provision of quality unit functions, development of QA/QC systems and phase-appropriate quality program implementation.
Vendor and site audits with local auditor engagement across multiple geographies.
Hands-on CMC support including preparation for manufacturing, API outsourcing advice, and oversight of manufacturing partners.
Expertise Areas
- CMC and formulation development
- Non-clinical development (DMPK, toxicology, pharmacology)
- Regulatory strategy and global submissions
- Quality assurance, QA/QC and auditing
Key Technologies
- CMC development
- Formulation development
- DMPK studies
- Toxicology studies
News & Updates
A retrospective article reflecting on two decades of pharmaceutical outsourcing and industry evolution.
Industry event focused on pharmaceutical outsourcing.
Article discussing investment in life sciences, including insights relevant to pharmaceutical development.
News about Solutia divesting its consulting arm, which is related to the company's history.
An article providing strategies for pharmaceutical companies to navigate the changing landscape of Contract Development and Manufacturing Organizations.
An article discussing risk management strategies in pharmaceutical outsourcing.
A retrospective article reflecting on two decades of pharmaceutical outsourcing and industry evolution.
Industry event focused on pharmaceutical outsourcing.
Article discussing investment in life sciences, including insights relevant to pharmaceutical development.
News about Solutia divesting its consulting arm, which is related to the company's history.
An article providing strategies for pharmaceutical companies to navigate the changing landscape of Contract Development and Manufacturing Organizations.
An article discussing risk management strategies in pharmaceutical outsourcing.